Cholangiocarcinoma electrochemotherapy
WebOBJECTIVE: Cholangiocarcinoma (CCA) is the second most common primary hepatic malignancy after hepatocellular carcinoma. The current standard palliative treatment, … WebMar 1, 2003 · Electrochemotherapy is a local drug delivery approach aimed at treatment with palliative intent of cutaneous and subcutaneous tumour nodules of different …
Cholangiocarcinoma electrochemotherapy
Did you know?
WebMar 1, 2003 · Electrochemotherapy is a local drug delivery approach aimed at treatment with palliative intent of cutaneous and subcutaneous tumour nodules of different histologies. ... no significant difference was observed. Cholangiocarcinoma patients with CD133- and/or Oct3/4-positive tumor tissues showed significantly lower expression of Mn-SOD … WebJun 1, 2024 · Intrahepatic cholangiocarcinoma (iCCA) is the second most common primary liver tumor, with a median survival of only 13 months. Surgical resection remains the only curative therapy; however, at ...
WebJul 2, 2024 · Hilar cholangiocarcinoma, also known as a Klatskin tumor, is a form of ductal adenocarcinoma involving a common bile duct and the bifurcation of intrahepatic ducts. WebMost of the patients with cholangiocarcinoma (CCA) present with advanced (inoperable or metastatic) disease, and relapse rates are high in those undergoing potentially curative …
WebMar 12, 2014 · Electrochemotherapy is a local treatment of cancer employing electric pulses to improve transmembrane transfer of cytotoxic drugs. In this paper we discuss … WebOct 1, 2024 · Cholangiocarcinoma (CCA) represents less than 2% of all human neoplasms and is the second most common primary hepatic malignancy after hepatocellular …
WebMar 19, 2024 · Introduction: Cholangiocarcinoma (CCA) is the second most common primary tumor of the liver, and the recurrence after hepatic resection (HR), the only curative therapy, is linked with a worse prognosis. Systemic chemotherapy (SC) and liver loco-regional treatments, like trans-arterial chemoembolization (TACE) or radio embolization …
WebOct 1, 2024 · Cholangiocarcinoma (CCA) represents less than 2% of all human neoplasms and is the second most common primary hepatic malignancy after hepatocellular carcinoma, ... Electrochemotherapy induces coagulation necrosis (due to obstructed vessels), of the treated area containing both tumor and normal tissues [37]. ECT induces similar changes … gcp in ethics reviewWebOct 7, 2024 · Bertino G, Muir T, Odili J, et al. Treatment of basal cell carcinoma with electrochemotherapy: insights from the InspECT Registry (2008-2024). Curr Oncol. … days to display flagWebNov 1, 2024 · Electrochemotherapy can be used to treat solid cutaneous and subcutaneous tumors, such as melanoma, basal cell carcinoma and squamous cell carcinoma. Electric fields used in irreversible electroporation and electrochemotherapy respect collagenic structure of the surrounding tissue offering promising options for tumor … gcp in chinaWebCholangiocarcinoma is a disease entity comprising diverse epithelial tumours with features of cholangiocyte differentiation: cholangiocarcinomas are categorized according to anatomical location as intrahepatic (iCCA), perihilar (pCCA), or distal (dCCA). Each subtype has a distinct epidemiology, biology, prognosis, and strategy for clinical ... days to easter 2023days to display the texas flagWebMar 19, 2024 · PDF Introduction: Cholangiocarcinoma (CCA) is the second most common primary tumor of the liver, and the recurrence after hepatic resection (HR), the... Find, read and cite all the research ... gcp in financeWebMar 1, 2024 · Electrochemotherapy (ECT) is a promising tool for treatment of deep tumours. ... (HCC) and combined hepatocellular and cholangiocarcinoma (cHCC‐CC) with FDG‐PET have been reported so far ... gcp industry